Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03)

World Biggest Tenders Source

This tender with title Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03) has been published on Bidding Source portal dated 16 Jul 2019 for the country of Germany. It has been categorized on Endocrine therapy medicinal products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03)

Tender Type :

Contract notice

Reference No. :

2019/S 134-329035

Country :

Germany

Province/City :

Germany-Hanover

Publish Date :

16 Jul 2019

Closing Date :

27 Jun 2021

Notice Language :

English

Tender Categories (CPVs) :

Endocrine therapy medicinal products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Germany - Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient fulvestrant (ATC code: L02BA03). -- Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03). Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) -- Endocrine therapy medicinal products Germany Endocrine therapy medicinal products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) Germany Germany-Hanover: Endocrine therapy medicinal products Germany 554980-Awarded - Portugal – Endocrine therapy medicinal products – 2024/0780 - OCTREOTIDO [20 MG/ 2 ML; IM; F/AMP] Portugal 556869-Awarded - Portugal – Endocrine therapy medicinal products – 2024/0780 - OCTREOTIDO [20 MG/ 2 ML; IM; F/AMP] Portugal 557075-Awarded - Portugal – Endocrine therapy medicinal products – 2024/0780 - OCTREOTIDO [20 MG/ 2 ML; IM; F/AMP] Portugal 547519-Awarded - Cyprus – Endocrine therapy medicinal products – Tender for the supply of Fulvestrant 250mg/5ml solution for injection - no. diag. 81/2025 (OAY) -- Contract Value: 198 450,00 EUR Cyprus PROCUREMENT OF DRUGS USED IN MANAGEMENT OF ENDOCRINE DISORDERS (ANNUAL REQUIREMENT) HEALTH/IFB/2025/2288 - 6999133 Mauritius Tender for the Supply of Leuprorelin Acetate 3.75mg Suspension for Injection - 8334649 Malta

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03)

General Information

Germany

Similar Tenders

Endocrine therapy medicinal products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com